Article Information
History
- January 1, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Cory A. Perugino1,2,
- Hang Liu1,
- Jared Feldman1,
- Blake M. Hauser1,
- Catherine Jacob-Dolan1,10,
- Anusha Nathan1,
- Zezhou Zhou1,
- Clarety Kaseke1,
- Rhoda Tano-Menka1,
- Matthew A. Getz1,
- Fernando Senjobe1,
- Cristhian Berrios3,
- Onosereme Ofoman3,
- Jacob E. Lemieux4,5,
- Marcia B. Goldberg4,
- Kerstin Nundel6,
- Ann Moormann6,
- Ann Marshak-Rothstein6,
- John A. Iafrate3,
- Gaurav Gaiha1,7,
- Richelle Charles4,
- Alejandro B. Balazs1,
- Vivek Naranbhai8,9,10,
- Aaron G. Schmidt1,11 and
- Shiv Pillai1,*
- 1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
- 2Division of Rheumatology Allergy and Immunology, Massachusetts General Hospital, Boston, MA 02114, USA
- 3Department of Pathology, Massachusetts Hospital, Boston, MA 02114, USA
- 4Infectious Diseases Division, Massachusetts Hospital, Boston, MA 02114, USA
- 5Broad Institute of MIT and Harvard, Cambridge MA 02139, USA
- 6University of Massachusetts Medical School, Worcester MA 01605, USA
- 7Gastrointestinal Unit, Massachusetts Hospital, Boston, MA 02114, USA
- 8MGH Cancer Center, Massachusetts Hospital, Boston, MA 02114, USA
- 9Dana-Farber Cancer Institute, Boston, MA 02215, USA
- 9Center for the AIDS Programme of Research in South Africa, Durban 4001, South Africa
- 10Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston MA 02115
- 11Department of Microbiology, Harvard Medical School, Boston MA 02115
- ↵*Correspondence: pillai{at}helix.mgh.harvard.edu (S.P.)
Posted January 01, 2022.
Preferential expansion upon boosting of cross-reactive “pre-existing” switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein
